Financial Information FinancialMenu Fundamentals Financial Information Quarterly Results Key Ratios Annual Reports Here you will find a summary of Alnylam Pharmaceuticals, Inc.'s latest financial information. Show all Latest Earnings Release and 10-Q Second Quarter Financial Results Form 10-Q Show all Latest Annual Report and 10-K 2018 Annual Report 13.8 MB Form 10-K Show all Latest Proxy Statement Latest Proxy Statement Share Related Items Market Capitalization (Mil) $8,973.35 Shares Outstanding (Mil) 111.21 Shares Outstanding, Average (FY) (Mil) 100.59 Float (Mil) 110.28 Copyright Thomson Reuters Corporation FY = Fiscal Year. MRQ = Most Recent Quarter. mil = Millions. TTM = Trailing Twelve Months.